Protective effect of mitochondria-targeted antioxidants in an acute bacterial infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 33, 2013, Pages

  Plotnikov, Egor Y ^a   Morosanova, Maria A ^a   Pevzner, Irina B ^a   Zorova, Ljubava D ^a   Manskikh, Vasily N ^a   Pulkova, Natalya V ^a   Galkina, Svetlana I ^a   Skulachev, Vladimir P ^a   Zorov, Dmitry B ^a  

^a MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Inflammation; Innate immunity; Phenoptosis; Toll like receptors; Urological diseases

Indexed keywords

ANTIOXIDANT; MITOCHONDRIA TARGETED ANTIOXIDANT SKQR 1; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ACUTE PYELONEPHRITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CELL DEATH; KIDNEY CELL; KIDNEY INJURY; KIDNEY PARENCHYMA; LEUKOCYTE ACTIVATION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENAL PROTECTION; SURVIVAL;

INFLAMMATION; INNATE IMMUNITY; PHENOPTOSIS; TOLL-LIKE RECEPTORS; UROLOGICAL DISEASES;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; ESCHERICHIA COLI; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, SCANNING; MITOCHONDRIA; OXIDATIVE STRESS; PEROXIDASE; PLASTOQUINONE; PROTO-ONCOGENE PROTEINS C-BCL-2; PYELONEPHRITIS; RATS; REACTIVE OXYGEN SPECIES; RHODAMINES;

EID: 84882298219     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1307096110     Document Type: Article

References (65)

1. O'Hanley P (1996) Prospects for urinary tract infection vaccines. Urinary Tract Infections: Molecular Pathogenesis and Clinical Management, eds Mobley HLT, Warren JW (American Society for Microbiology, Washington, DC), pp 405-425.
2. Hill JB, Sheffield JS, McIntire DD, Wendel GD, Jr. (2005) Acute pyelonephritis in pregnancy. Obstet Gynecol 105(1):18-23.
3. Trifillis AL, et al. (1994) Binding to and killing of human renal epithelial cells by hemolytic P-fimbriated E. coli. Kidney Int 46(4):1083-1091.
4. Uhlén P, et al. (2000) Alpha-haemolysin of uropathogenic E. coli induces Ca2+ oscillations in renal epithelial cells. Nature 405(6787):694-697.
5. O'Hanley P, Lalonde G, Ji G (1991) Alpha-hemolysin contributes to the pathogenicity of piliated digalactoside-binding Escherichia coli in the kidney: Efficacy of an alphahemolysin vaccine in preventing renal injury in the BALB/c mouse model of pyelonephritis. Infect Immun 59(3):1153-1161.
6. Smith YC, Rasmussen SB, Grande KK, Conran RM, O'Brien AD (2008) Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect Immun 76(7):2978-2990.
7. Montini G, Tullus K, Hewitt I (2011) Febrile urinary tract infections in children. N Engl J Med 365(3):239-250.
8. Pistor K, Schärer K, Olbing H, Tamminen-Möbius T (1985) Children with chronic renal failure in the Federal Republic of Germany. II. Primary renal diseases, age and intervals from early renal failure to renal death. Clin Nephrol 23(6):278-284.
9. Gupta A, Sharma S, Nain CK, Sharma BK, Ganguly NK (1996) Reactive oxygen speciesmediated tissue injury in experimental ascending pyelonephritis. Kidney Int 49(1): 26-33.
10. Friedewald JJ, Rabb H (2004) Inflammatory cells in ischemic acute renal failure. Kidney Int 66(2):486-491.
11. Mundi H, Björkstén B, Svanborg C, Ohman L, Dahlgren C (1991) Extracellular release of reactive oxygen species from human neutrophils upon interaction with Escherichia coli strains causing renal scarring. Infect Immun 59(11):4168-4172.
12. Nassar GM, Badr KF (1998) Novel approaches to treatment of glomerulonephritis. J Nephrol 11(4):177-184.
13. Aydogdu N, et al. (2006) Protective effects of L-carnitine on myoglobinuric acute renal failure in rats. Clin Exp Pharmacol Physiol 33(1-2):119-124.
14. Koyner JL, Sher Ali R, Murray PT (2008) Antioxidants: Do they have a place in the prevention or therapy of acute kidney injury? Nephron, Exp Nephrol 109(4): e109-e117.
15. Polo-Romero FJ, Fernández-Fúnez A, Broseta Viana L, Atienza MP, Sánchez Gascón F (2004) Effect of N-acetylcysteine on antioxidant status in glycerol-induced acute renal failure in rats. Ren Fail 26(6):613-618.
16. Rodrigo R, Bosco C, Herrera P, Rivera G (2004) Amelioration of myoglobinuric renal damage in rats by chronic exposure to flavonol-rich red wine. Nephrol Dial Transplant 19(9):2237-2244.
17. Sadeghi Z, et al. (2008) Vitamin E administration at the onset of fever prevents renal scarring in acute pyelonephritis. Pediatr Nephrol 23(9):1503-1510.
18. Singh D, Chander V, Chopra K (2004) Protective effect of naringin, a bioflavonoid on glycerol-induced acute renal failure in rat kidney. Toxicology 201(1-3):143-151.
19. Sanmun D, et al. (2009) Involvement of a functional NADPH oxidase in neutrophils and macrophages during programmed cell clearance: Implications for chronic granulomatous disease. Am J Physiol Cell Physiol 297(3):C621-C631.
20. Plotnikov EY, Chupyrkina AA, Pevzner IB, Isaev NK, Zorov DB (2009) Myoglobin causes oxidative stress, increase of NO production and dysfunction of kidney's mitochondria. Biochim Biophys Acta 1792(8):796-803.
21. Plotnikov EY, et al. (2010) New-generation Skulachev ions exhibiting nephroprotective and neuroprotective properties. Biochemistry (Mosc) 75(2):145-150.
22. Skulachev VP, et al. (2009) An attempt to prevent senescence: A mitochondrial approach. Biochim Biophys Acta 1787(5):437-461.
23. Smith RA, et al. (2008) Mitochondria-targeted antioxidants in the treatment of disease. Ann N Y Acad Sci 1147:105-111.
24. Antonenko YN, et al. (2008) Protective effects of mitochondria-targeted antioxidant SkQ in aqueous and lipid membrane environments. J Membr Biol 222(3):141-149.
25. Bakeeva LE, et al. (2008) Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program.
26. Treatment of some ROS- and agerelated diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke). Biochemistry (Mosc) 73(12):1288-1299.
27. Agapova LS, et al. (2008) Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program.
28. Inhibitory effect of SkQ1 on tumor development from p53-deficient cells. Biochemistry (Mosc) 73(12):1300-1316.
29. Neroev VV, et al. (2008) Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program.
30. Age-related eye disease. SkQ1 returns vision to blind animals. Biochemistry (Mosc) 73(12):1317-1328.
31. Anisimov VN, et al. (2008) Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program.
32. SkQ1 prolongs lifespan and prevents development of traits of senescence. Biochemistry (Mosc) 73(12):1329-1342.
33. Liberman EA, Topaly VP, Tsofina LM, Jasaitis AA, Skulachev VP (1969) Mechanism of coupling of oxidative phosphorylation and the membrane potential of mitochondria. Nature 222(5198):1076-1078.
34. Sakaguchi S, Furusawa S, Wu J, Nagata K (2007) Preventive effects of a biscoclaurine alkaloid, cepharanthine, on endotoxin or tumor necrosis factor-alpha-induced septic shock symptoms: Involvement of from cell death in L929 cells and nitric oxide production in raw 264.7 cells. Int Immunopharmacol 7(2):191-197.
35. Morandi B, et al. (2011) A mixture of bacterial mechanical lysates is more efficient than single strain lysate and of bacterial-derived soluble products for the induction of an activating phenotype in human dendritic cells. Immunol Lett 138(1):86-91.
36. Sanchez-Niño MD, et al. (2010) TNF superfamily: A growing saga of kidney injury modulators. Mediators Inflamm 2010:182958.
37. Galkina SI, et al. (2004) Endothelium-leukocyte interactions under the influence of the superoxide-nitrogen monoxide system. Med Sci Monit 10(9):BR307-BR316.
38. Giamarellos-Bourboulis EJ, et al. (2006) Oleuropein: A novel immunomodulator conferring prolonged survival in experimental sepsis by Pseudomonas aeruginosa. Shock 26(4):410-416.
39. Meylan PR, Glauser MP (1989) Role of complement-derived and bacterial formylpeptide chemotactic factors in the in vivo migration of neutrophils in experimental Escherichia coli pyelonephritis in rats. J Infect Dis 159(5):959-965.
40. Hunter DR, Haworth RA (1979) The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch Biochem Biophys 195(2):453-459.
41. Zoratti M, Szabò I (1995) The mitochondrial permeability transition. Biochim Biophys Acta 1241(2):139-176.
42. Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 86(1):147-157.
43. Zamzami N, et al. (1996) Mitochondrial control of nuclear apoptosis. J Exp Med 183(4):1533-1544.
44. Skulachev VP (1996) Why are mitochondria involved in apoptosis? Permeability transition pores and apoptosis as selective mechanisms to eliminate superoxideproducing mitochondria and cell. FEBS Lett 397(1):7-10.
45. Zorov DB, Filburn CR, Klotz LO,Zweier JL, Sollott SJ (2000) Reactive oxygen species (ROS)- inducedROSrelease:Anewphenomenonaccompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 192(7):1001-1014.
46. Zorov DB, Juhaszova M, Sollott SJ (2006) Mitochondrial ROS-induced ROS release: An update and review. Biochim Biophys Acta 1757(5-6):509-517.
47. Kroemer G, Petit P, Zamzami N, Vayssière JL, Mignotte B (1995) The biochemistry of programmed cell death. FASEB J 9(13):1277-1287.
48. Cherubini A, Ruggiero C, Polidori MC, Mecocci P (2005) Potential markers of oxidative stress in stroke. Free Radic Biol Med 39(7):841-852.
49. Gupta A, Sharma N, Sharma BK, Sharma S, Ganguly NK (1996) Oxygen-dependent and -independent mechanisms of renal injury in experimental ascending pyelonephritis. FEMS Immunol Med Microbiol 13(1):35-42.
50. Skulachev VP (2002) Programmed death phenomena: from organelle to organism. Ann NY Acad Sci 959: 214-237.
51. Bennett RT, Mazzaccaro RJ, Chopra N, Melman A, Franco I (1999) Suppression of renal inflammation with vitamins A and E in ascending pyelonephritis in rats. J Urol 161(5): 1681-1684.
52. Haraoka M, et al. (1994) Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats. J Urol 151(4):1078-1080.
53. Imamoglu M, et al. (2006) Effects of melatonin on suppression of renal scarring in experimental model of pyelonephritis. Urology 67(6):1315-1319.
54. Shirali AC, Goldstein DR (2008) Tracking the toll of kidney disease. J Am Soc Nephrol 19(8):1444-1450.
55. Li YH, Yan ZQ, Brauner A, Tullus K (2002) Activation of macrophage nuclear factorkappa B and induction of inducible nitric oxide synthase by LPS. Respir Res 3(1):23.
56. Ragnarsdottir B, et al. (2008) TLR- and CXCR1-dependent innate immunity: Insights into the genetics of urinary tract infections. Eur J Clin Invest 38(Suppl 2):12-20.
57. Tullus K, Escobar-Billing R, Fituri O, Lu Y, Brauner A (1997) Soluble receptors to tumour necrosis factor and interleukin-6 in urine during acute pyelonephritis. Acta Paediatr 86(11):1198-1202.
58. Clem RJ, et al. (1998) Modulation of cell death by Bcl-XL through caspase interaction. Proc Natl Acad Sci USA 95(2):554-559.
59. Cheng EH, et al. (1997) Conversion of Bcl-2 to a Bax-like death effector by caspases. Science 278(5345):1966-1968.
60. Juhaszova M, et al. (2004) Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest 113(11):1535-1549.
61. Medzhitov R, Schneider DS, Soares MP (2012) Disease tolerance as a defense strategy. Science 335(6071):936-941.
62. Antonenko YN, et al. (2008) Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program.
63. Cationic plastoquinone derivatives: synthesis and in vitro studies. Biochemistry (Mosc) 73(12):1273-1287.
64. Gupta R, Ganguly NK, Ahuja V, Joshi K, Sharma S (1995) An ascending non-obstructive model for chronic pyelonephritis in BALB/c mice. J Med Microbiol 43(1):33-36.
65. Mihara M, Uchiyama M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86(1):271-278.